Novo Nordisk
Develops medicines and devices for chronic diseases like diabetes, obesity, and rare disorders.
NOVO | CO
Overview
Corporate Details
- ISIN(s):
- DK0062498333 (+1 more)
- LEI:
- 549300DAQ1CVT6CXN342
- Country:
- Denmark
- Address:
- Novo Alle 1, 2880 Bagsværd
- Website:
- https://www.novonordisk.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Novo Nordisk is a global healthcare company that discovers, develops, and manufactures innovative biological medicines and therapeutic devices. With a focus on driving change to defeat serious chronic diseases, the company's primary treatment areas include diabetes, obesity, and rare blood and endocrine disorders. Leveraging over 90 years of innovation, Novo Nordisk provides pharmaceutical products and services to patients worldwide, aiming to make its treatments accessible and improve health outcomes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-17 14:58 |
Director's Dealing
|
English | 16.2 KB | ||
| 2025-11-17 14:58 |
Regulatory News Service
|
English | 123.6 KB | ||
| 2025-11-11 14:39 |
Director's Dealing
|
English | 26.7 KB | ||
| 2025-11-11 14:39 |
Regulatory News Service
|
English | 155.6 KB | ||
| 2025-11-06 19:01 |
Regulatory News Service
|
English | 143.7 KB | ||
| 2025-11-06 19:01 |
Regulatory News Service
|
English | 6.0 KB | ||
| 2025-10-30 10:49 |
M&A Activity
|
English | 74.8 KB | ||
| 2025-10-30 10:49 |
M&A Activity
|
English | 5.3 KB | ||
| 2025-10-21 13:56 |
Board/Management Information
|
English | 7.2 KB | ||
| 2025-10-21 13:56 |
Board/Management Information
|
English | 78.0 KB | ||
| 2025-10-09 12:00 |
M&A Activity
|
English | 12.9 KB | ||
| 2025-10-09 12:00 |
M&A Activity
|
English | 124.0 KB | ||
| 2025-09-10 07:00 |
Regulatory News Service
|
English | 11.2 KB | ||
| 2025-09-10 07:00 |
Earnings Release
|
English | 151.5 KB | ||
| 2025-08-19 13:37 |
Director's Dealing
|
English | 17.4 KB |
Automate Your Workflow. Get a real-time feed of all Novo Nordisk filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Novo Nordisk
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Novo Nordisk via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
